Charles Atkinson

Array ( [id] => 5428563 [patent_doc_number] => 20090087873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'SHARPLY RESOLVING LABELED PROTEIN MOLECULAR WEIGHT STANDARDS' [patent_app_type] => utility [patent_app_number] => 11/781251 [patent_app_country] => US [patent_app_date] => 2007-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 38702 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087873.pdf [firstpage_image] =>[orig_patent_app_number] => 11781251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939354 [patent_doc_number] => 20080076673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'ENGINEERED BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/781188 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 42067 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076673.pdf [firstpage_image] =>[orig_patent_app_number] => 11781188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153424 [patent_doc_number] => 08586330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Methods for producing secreted polypeptides having biological activity' [patent_app_type] => utility [patent_app_number] => 12/373470 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23302 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12373470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354801 [patent_doc_number] => 20090186145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Composition for Preventing and Improving Metabolic Syndrome' [patent_app_type] => utility [patent_app_number] => 12/227951 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5071 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186145.pdf [firstpage_image] =>[orig_patent_app_number] => 12227951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121697 [patent_doc_number] => 07709441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Control of function of intracellular Ca ion' [patent_app_type] => utility [patent_app_number] => 11/811588 [patent_app_country] => US [patent_app_date] => 2007-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7259 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709441.pdf [firstpage_image] =>[orig_patent_app_number] => 11811588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977902 [patent_doc_number] => 20070219135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Pharmaceutical Composition Comprising Factor VII Polypeptides and PAI-1 Polypeptide' [patent_app_type] => utility [patent_app_number] => 11/756028 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18507 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219135.pdf [firstpage_image] =>[orig_patent_app_number] => 11756028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132820 [patent_doc_number] => 07696161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Exendin agonist compounds' [patent_app_type] => utility [patent_app_number] => 11/807031 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 21427 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696161.pdf [firstpage_image] =>[orig_patent_app_number] => 11807031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028386 [patent_doc_number] => 20070269833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'GALECTIN-GLYCOSAMINOGLYCAN COMPLEX AND METHOD FOR CONTROLLING GALECTIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/751106 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8936 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269833.pdf [firstpage_image] =>[orig_patent_app_number] => 11751106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162899 [patent_doc_number] => 07671185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Monomeric red fluorescent proteins' [patent_app_type] => utility [patent_app_number] => 11/748641 [patent_app_country] => US [patent_app_date] => 2007-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5233 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671185.pdf [firstpage_image] =>[orig_patent_app_number] => 11748641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9957969 [patent_doc_number] => 09006173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Microcystins as agents for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/798167 [patent_app_country] => US [patent_app_date] => 2007-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11702 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11798167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772602 [patent_doc_number] => 20080058261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Protease susceptibility II' [patent_app_type] => utility [patent_app_number] => 11/801120 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 19849 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058261.pdf [firstpage_image] =>[orig_patent_app_number] => 11801120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199193 [patent_doc_number] => 20070298511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Nanopore sensor system' [patent_app_type] => utility [patent_app_number] => 11/788293 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6959 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298511.pdf [firstpage_image] =>[orig_patent_app_number] => 11788293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368388 [patent_doc_number] => 20090305947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'LIVESTOCK MANAGEMENT FOR IMPROVED REPRODUCTIVE EFFICIENCY' [patent_app_type] => utility [patent_app_number] => 12/296523 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12402 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305947.pdf [firstpage_image] =>[orig_patent_app_number] => 12296523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168994 [patent_doc_number] => 07667019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Flea ultraspiracle nucleic acid molecules' [patent_app_type] => utility [patent_app_number] => 11/697551 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25414 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/667/07667019.pdf [firstpage_image] =>[orig_patent_app_number] => 11697551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6566521 [patent_doc_number] => 20100234277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'COADMINISTRATION OF ALPHA-FETOPROTEIN AND A DISEASE MODIFYING ANTI-RHEUMATIC DRUG FOR TREATING INFLAMMATORY ARTHRITIC DISEASE' [patent_app_type] => utility [patent_app_number] => 12/295017 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11610 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234277.pdf [firstpage_image] =>[orig_patent_app_number] => 12295017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131285 [patent_doc_number] => 07700334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Photoswitchable method for the ordered attachment of proteins to surfaces' [patent_app_type] => utility [patent_app_number] => 11/688171 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 5666 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700334.pdf [firstpage_image] =>[orig_patent_app_number] => 11688171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681724 [patent_doc_number] => 20080247950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Activation of peptide prodrugs by hK2' [patent_app_type] => utility [patent_app_number] => 11/725135 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8986 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20080247950.pdf [firstpage_image] =>[orig_patent_app_number] => 11725135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292474 [patent_doc_number] => 20100159512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'METHOD FOR THE PREPARATION OF RECOMBINANT HUMAN THROMBIN AND FIBRINOGEN' [patent_app_type] => utility [patent_app_number] => 12/281877 [patent_app_country] => US [patent_app_date] => 2007-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19783 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20100159512.pdf [firstpage_image] =>[orig_patent_app_number] => 12281877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4585073 [patent_doc_number] => 07851604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Transcriptional regulator' [patent_app_type] => utility [patent_app_number] => 11/709624 [patent_app_country] => US [patent_app_date] => 2007-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 31 [patent_no_of_words] => 12688 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851604.pdf [firstpage_image] =>[orig_patent_app_number] => 11709624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403948 [patent_doc_number] => 20090239262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Affinity Polypeptide for Purification of Recombinant Proteins' [patent_app_type] => utility [patent_app_number] => 12/161603 [patent_app_country] => US [patent_app_date] => 2007-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12061 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239262.pdf [firstpage_image] =>[orig_patent_app_number] => 12161603 [rel_patent_id] =>[rel_patent_doc_number] =>)